Details for Patent: 10,519,146
✉ Email this page to a colleague
Which drugs does patent 10,519,146 protect, and when does it expire?
Patent 10,519,146 protects LUMAKRAS and is included in one NDA.
This patent has seventy patent family members in thirty-six countries.
Summary for Patent: 10,519,146
| Title: | KRAS G12C inhibitors and methods of using the same |
| Abstract: | Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers. |
| Inventor(s): | Lanman; Brian Alan (Thousand Oaks, CA), Chen; Jian (Thousand Oaks, CA), Reed; Anthony B. (Thousand Oaks, CA), Cee; Victor J. (Thousand Oaks, CA), Liu; Longbin (Thousand Oaks, CA), Kopecky; David John (Thousand Oaks, CA), Lopez; Patricia (Thousand Oaks, CA), Wurz; Ryan Paul (Thousand Oaks, CA), Nguyen; Thomas T. (Thousand Oaks, CA), Booker; Shon (Thousand Oaks, CA), Nishimura; Nobuko (Thousand Oaks, CA), Shin; Youngsook (Thousand Oaks, CA), Tamayo; Nuria A. (Thousand Oaks, CA), Allen; John Gordon (Thousand Oaks, CA), Allen; Jennifer Rebecca (Thousand Oaks, CA) |
| Assignee: | Amgen Inc. (Thousand Oaks, CA) |
| Application Number: | 15/984,855 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Recent additions to Drugs Protected by US Patent 10,519,146
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen Inc | LUMAKRAS | sotorasib | TABLET | 214665 | May 28, 2021 | RX | Yes | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Amgen Inc | LUMAKRAS | sotorasib | TABLET | 214665 | Jun 26, 2024 | RX | Yes | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Amgen Inc | LUMAKRAS | sotorasib | TABLET | 214665 | Jan 20, 2023 | RX | Yes | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 10,519,146
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen Inc | LUMAKRAS | sotorasib | TABLET;ORAL | 214665-001 | May 28, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Amgen Inc | LUMAKRAS | sotorasib | TABLET;ORAL | 214665-003 | Jun 26, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Amgen Inc | LUMAKRAS | sotorasib | TABLET;ORAL | 214665-002 | Jan 20, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,519,146
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 111882 | ⤷ Sign Up | |||
| Argentina | 122783 | ⤷ Sign Up | |||
| Argentina | 122784 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
